GI & Endoscopy

Here are six gastroenterologists in the news this past week.

Family history may influence inflammatory bowel disease development, according to a study in Nature Genetics.

Smokers are more likely to experience Crohn's disease relapses after surgical intestinal resection, according to a study in The Lancet Gastroenterology & Hepatology.

The global gastrointestinal drugs market will continue to grow through 2022, according to a GBI Research report.

The gastroenterology endoscopic device market continues to be one of consistent upward movement, MDDI reports.

The FDA is requiring manufacturers to put 'black box' warnings on labels of direct-acting antiviral prescriptions because of the possibility that the drugs cause the hepatitis B virus to resurface, Gastroenterology and Endoscopy News reports.

The global endoscopic devices market is expected to grow at a CAGR of 7.06 percent until 2020, according to a NOVONOUS report.

Allergan has bought the rights to develop and commercialize MEDI2070, according to Zacks.

Here are three updates on gastroenterology and endoscopy companies.

A study in the American Journal of Gastroenterology examined the factors that lead to developing irritable bowel syndrome in travelers. Here's what you need to know.